Ambulatory blood pressure and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease

Renal Failure

Volumn 29, Issue 8, 2007, Pages 979-984

  Turgut, Faruk ^a,b   Oflaz, Hüseyin ^b   Namli, Sule ^a   Alisir, Sabahat ^a   Tufan, Fatih ^a   Temiz, Suleyman ^a   Umman, Sabahattin ^b   Ecder, Tevfik ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ambulatory blood pressure; Autosomal dominant polycystic kidney disease; Dipper; Endothelial dysfunction; Non dipper

Indexed keywords

ADULT; AMBULATORY MONITORING; ARTERY DIAMETER; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPEREMIA; INTRAVASCULAR ULTRASOUND; KIDNEY POLYCYSTIC DISEASE; MALE; PRIORITY JOURNAL; SAMPLE SIZE; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 36849014462     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701641728     Document Type: Article

References (25)

1. th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2001:547-588.
2. Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995;5:2048-2056.
3. Wang D, Iversen J, Wilcox CS, Strandgaard S. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int. 2003;64:1381-1388.
4. Kocaman O, Oflaz H, Yekeler E et al. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2004;43:854-860.
5. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension. 2005;46:156-161.
6. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure measurement. N Engl J Med. 2006;354:2368-2374.
7. Verdecchia P, Porcellati C, Schillati G et al. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
8. Li Kam Wa TC, Macnicol AM, Watson ML. Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 1997;12:2075-2080.
9. Ravine D, Gibson RN, Walker RG, et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet. 1994;343:824-827.
10. Sahn DJ, Demaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
11. Henry WL, Demaria A, Gramlak R, et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation. 1980;62:212-217.
12. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618, 1977.
13. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992.
14. Chapman AB, Johnson AM, Rainguet S et al. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1997; 8: 1292-1297.
15. Martinez-Vea A, Valero FA, Bardaji A et al. Left ventricular hypertrophy in hypertensive patients with %utosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohumoral factors. Am J Nephrol 2000; 20: 193-200.
16. Saggar-Malik AK, Missouris CG, Gill JS et al. Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. BMJ 1994; 309:1617-1618.
17. Bardaji A, Martinez-Vea A, Gutierrez C et al. Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1998;32:970-975.
18. Zeier M, Geberth S, Schmidf KG, et al. Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1993;3:1451-1457.
19. Valero FA, Martinez-Vea A, Bardaji A, et al. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1999;10:1020-1026.
20. Oflaz H, Alisir A, Buyukaydin B, et al. Biventricular diastolic dysfunction in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2005;68:2244-2249.
21. Martinez-Vea A, Bardaji A, Gutierrez C, et al. Exercise blood pressure, cardiac structure, and diastolic dysfunction in young normotensive patients with polycystic kidney disease: A prehypertensive state. Am J Kidney Dis. 2004;44:216-223.
22. Verdecchia P, Schillaci G, Reboldi G, Franklin S, Porcellati C. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation. 2001;103:2579-2584.
23. Seeman T, Dusek J, Vondrichova H, et al. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. Blood Pres Monit. 2003;3:107-110.
24. Seeman T, Dusek J, Vondrak K, et al. Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease. Physiol Res. 2004;53:629-634.
25. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial dysfunction in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26: 1235-1241.